Prostate Biopsy in Active Surveillance Protocols: Immediate Re-biopsy and Timing of Subsequent Biopsies.

about

Prostate Biopsy in Active Surveillance Protocols: Immediate Re-biopsy and Timing of Subsequent Biopsies.

Item

http://www.wikidata.org/entity/Q39356200

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Prostate Biopsy in Active Surv ...... Timing of Subsequent Biopsies.

@en

Prostate Biopsy in Active Surv ...... Timing of Subsequent Biopsies.

@nl

type

Item

label

Prostate Biopsy in Active Surv ...... Timing of Subsequent Biopsies.

@en

Prostate Biopsy in Active Surv ...... Timing of Subsequent Biopsies.

@nl

prefLabel

Prostate Biopsy in Active Surv ...... Timing of Subsequent Biopsies.

@en

Prostate Biopsy in Active Surv ...... Timing of Subsequent Biopsies.

@nl

P1476

Prostate Biopsy in Active Surv ...... Timing of Subsequent Biopsies.

@en

P2093

David F Jarrard

http://www.w3.org/2001/XMLSchema#string

E Jason Abel

http://www.w3.org/2001/XMLSchema#string

Jonathan H Wang

http://www.w3.org/2001/XMLSchema#string

Kyle A Richards

http://www.w3.org/2001/XMLSchema#string

Tracy M Downs

http://www.w3.org/2001/XMLSchema#string

P2860

Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference

Radical prostatectomy or watchful waiting in early prostate cancer.

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer.

Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.

Characteristics and experiences of patients with localized prostate cancer who left an active surveillance program.

Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification.

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.

Risk stratification of men choosing surveillance for low risk prostate cancer.

Saturation biopsy for detecting and characterizing prostate cancer.

P2888

s11934-017-0702-y

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11934-017-0702-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28589399

http://www.w3.org/2001/XMLSchema#string

P921

biopsy